Page 111 - 2017食品藥物管理署年報(英文版)

2017 Taiwan Food and Drug Administration Annual Report Chapter 7. International Cooperation and Cross-strait Exchanges

on the professions of academic/research fields or civil groups to promote cross-strait

business cooperation in food safety. Through cross-strait department leaders/experts
routine meetings, the organization of conferences or seminars, visiting food-related
institutes and businesses, TFDA facilitates cross-strait collaboration in food safety
surveillance and reaches consensus for management.
As of medicinal products, “Cross-Strait Cooperation Agreement on Medicine
and Public Health Affairs” was signed by Taiwan and China in 2010. TFDA thereby
established “The Working Group on Safety Administration and Research and

Development of Medicinal Products” and set four taskforces (i.e. medicinal products
and cosmetics, medical devices, health food and testing methods) to discuss bilateral
cooperation mechanisms, construct systemic work frame platform, assure product
quality and safety management, handle significant safety incidents relating to medicinal
products and coordinate standards and regulations. TFDA also implemented clinical
trial collaboration projects to learn implementation outcomes from each other, and fully
use bilateral medicinal products management and research capacity to develop safe and
effective medicinal products for the public.

Policies and Outcomes

1. Systemic meetings
(1) Food
In 2016, TFDA hosted several cross-strait food safety seminars in Taiwan and invited
representatives from food associations and businesses to participate, including “Seminars

for Food safety risk evaluation: The meaning of scientific, operational regulations and
food safety protection in Taiwan”, “Seminar for cross-strait online trading – food safety
management regulations and practice”, “2016 International seminar for microorganisms
and food safety management”, “Round table seminar for cross-strait microorganism
standards and testing” and “Seminar for the application of big data in food safety
management”.

(2) Medicinal products
TFDA and China Food and Drug Administration promulgated “Cross-strait clinical
trial center collaboration – reduce test duplication on April 25, 2016 based on ” “Cross-
Strait Cooperation Agreement on Medicine and Public Health Affaris”: a total of 8
clinical trial centers, including National Taiwan University Hospital, Taipei Veterans

General Hospital, Chang Gung Medical Foundation - Linkou branch, Tri-Service General
Hospital, Peking Union Medical College Hospital, Peking University First Hospital,
Shanghai Fudan University Zhongshan Hospital, Shanghai Jiao Tong University Ruijin

109